CD274 and neoplasm: According to PD-L1 tumor expression (positive PD-L1≥5% versus negative PD-L1<5%), a higher ORR (14.3% versus 8.0%) and a longer PFS (17.1 weeks versus 7.4 weeks) were observed in the PD-L1-positive group (16).